Gringeri A - Search Results

1

No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate.

Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Santagostino E, Tradati FC, Rosenberg RD. Mannucci PM, et al. Among authors: gringeri a. Br J Haematol. 1991 Dec;79(4):606-11. doi: 10.1111/j.1365-2141.1991.tb08088.x. Br J Haematol. 1991. PMID: 1772782

2

Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII.

Gringeri A, Tagliaferri A, Tagariello G, Morfini M, Santagostino E, Mannucci P; ReFacto-AICE Study Group. Gringeri A, et al. Br J Haematol. 2004 Aug;126(3):398-404. doi: 10.1111/j.1365-2141.2004.05058.x. Br J Haematol. 2004. PMID: 15257713 Free article. Clinical Trial.

3

Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura.

Gringeri A, Cattaneo M, Santagostino E, Mannucci PM. Gringeri A, et al. Br J Haematol. 1992 Mar;80(3):337-40. doi: 10.1111/j.1365-2141.1992.tb08142.x. Br J Haematol. 1992. PMID: 1581213

4

Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.

Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Bottasso B, Simoni L, Rosenberg RD. Mannucci PM, et al. Among authors: gringeri a. Blood. 1990 Dec 15;76(12):2540-5. Blood. 1990. PMID: 2265248 Free article. Clinical Trial.

5

Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery.

Santagostino E, Mannucci PM, Gringeri A, Tagariello G, Baudo F, Bauer KA, Rosenberg RD. Santagostino E, et al. Among authors: gringeri a. Thromb Haemost. 1994 Jun;71(6):737-40. Thromb Haemost. 1994. PMID: 7974341 Clinical Trial.

6

Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.

Cattaneo M, Simoni L, Gringeri A, Mannucci PM. Cattaneo M, et al. Among authors: gringeri a. Br J Haematol. 1994 Feb;86(2):333-7. doi: 10.1111/j.1365-2141.1994.tb04735.x. Br J Haematol. 1994. PMID: 8199023

7

A prospective clinical trial of implantable central venous access in children with haemophilia.

Santagostino E, Gringeri A, Muça-Perja M, Mannucci PM. Santagostino E, et al. Among authors: gringeri a. Br J Haematol. 1998 Sep;102(5):1224-8. doi: 10.1046/j.1365-2141.1998.00909.x. Br J Haematol. 1998. PMID: 9753049 Free article. Clinical Trial.

8

Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention.

Santagostino E, Gringeri A, Mannucci PM. Santagostino E, et al. Among authors: gringeri a. Br J Haematol. 1999 Jan;104(1):22-6. doi: 10.1046/j.1365-2141.1999.01128.x. Br J Haematol. 1999. PMID: 10027707 Free article. Clinical Trial.

9

State of care for hemophilia in pediatric patients.

Santagostino E, Gringeri A, Mannucci PM. Santagostino E, et al. Among authors: gringeri a. Paediatr Drugs. 2002;4(3):149-57. doi: 10.2165/00128072-200204030-00002. Paediatr Drugs. 2002. PMID: 11909007 Review.

10

Long-term safety and feasibility of arteriovenous fistulae as vascular accesses in children with haemophilia: a prospective study.

Santagostino E, Gringeri A, Berardinelli L, Beretta C, Muça-Perja M, Mannucci PM. Santagostino E, et al. Among authors: gringeri a. Br J Haematol. 2003 Nov;123(3):502-6. doi: 10.1046/j.1365-2141.2003.04632.x. Br J Haematol. 2003. PMID: 14617014 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters